Memorial Sloan Kettering Cancer Center
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Memorial Sloan Kettering Cancer Center sits in the top decile of US sponsors by registered trial count (#6 of 15,751 sponsors by registered trial count).
Memorial Sloan Kettering Cancer Center: 1,884 sponsored US clinical trials, 327 recruiting.
Memorial Sloan Kettering Cancer Center sponsors 1,884 registered US clinical trials on ClinicalTrials.gov, 327 of them currently recruiting, and 1,104 completed. 75 of these trials are in Phase 3-4 (later-stage) and 1,101 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Breast Cancer, with 98 trials.
Top-decile sponsor footprint
Memorial Sloan Kettering Cancer Center ranks in the top decile of sponsors by registered trial count (#6 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
1,884 total, page 6 of 38
Novel Imaging Technique to Assess Gynecologic Cancer
NCT04893434
Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With Surgery
NCT04891289
A Study of Intra-operative Imaging in Women With Ovarian Cancer
NCT04878094
A Study of ASTX727 in People With Malignant Peripheral Nerve Sheath Tumors (MPNST)
NCT04872543
A Study of Radiation Therapy With Pembrolizumab and Olaparib or Other Radiosensitizers in Women Who Have Triple-Negative or Hormone-Receptor Positive/Her2 Negative Breast Cancer
NCT04683679
Radiation and TSR-042 (Dostarlimab) in People With Endometrial Cancer After They Receive Surgery
NCT04774419
Changes in Reproductive and Sexual Health in People With Early Onset Colorectal Cancer
NCT04812912
The Use of Nanoparticles to Guide the Surgical Treatment of Prostate Cancer
NCT04167969
A Study of Noninvasive Methods to Evaluate Skin and Mucosal Conditions
NCT04743362
Iomab-ACT: A Pilot Study of 131-I Apamistamab Followed by CD19-Targeted CAR T-Cell Therapy for Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia or Diffuse Large B-Cell Lymphoma
NCT04512716
A New Psychotherapy Intervention for Older Cancer Patients
NCT04452825
A Study of Cemiplimab With Chemotherapy and Immunotherapy in People With Head and Neck Cancer
NCT04722523
Intracavitary Carrier-embedded Cs131 Brachytherapy for Recurrent Brain Metastases: a Randomized Phase II Study
NCT04690348
Registry to Collect Health Information About Desmoplastic Small Round Cell Tumor
NCT04690374
Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation
NCT04668872
Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders
NCT04644016
Exercise Therapy to Improve Cardiovascular Health in Post-Menopausal Women After Treatment for Early Stage Breast Cancer
NCT04458532
Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma
NCT04577014
Neurocutaneous Melanocytosis Registry
NCT04548817
Collection of Information to Better Understand Young Onset Colorectal Cancer
NCT04489238
Measuring Cell-Free DNA (cfDNA) Levels in People With Follicular Lymphoma
NCT04468841
Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers
NCT04410796
A Study of Pembrolizumab Plus Local Chemotherapy Using Isolated Limb Infusion (ILI) for Patients With Sarcoma in the Arm or Leg
NCT04332874
Association Between Exercise, Patient-Reported Outcomes, and Clinical Events in Adult Cancer Survivors
NCT07030686
Study of CAR-T Therapy in Older Patients
NCT04300998
Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease
NCT04291612
Observing People With Desmoid-Type Fibromatosis
NCT04281381
Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors
NCT04165772
PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56
NCT04199741
Tissue Analysis After Tumor Ablation for Liver Metastases Leading to Immediate Retreatment
NCT04143516
Looking at Cognitive and Brain Changes in People With Lymphoma Receiving CAR-T Therapy
NCT04107285
Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer
NCT04084730
Supportive Care Needs of Caregivers of People With Erdheim-Chester Disease and Other Histiocytic Diseases
NCT03990428
Discovering New Genetic Markers in Adults and Children Who May Be At Risk for Hereditary Forms of Cancer
NCT03922893
Study of Zanubrutinib, Obinutuzumab, and Venetoclax in Patients With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL)
NCT03824483
Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease
NCT03808337
Psychotherapy Intervention for Latinos With Adv Cancer
NCT04537936
Lesion Dosimetry With Iodine-124 in Metastatic Thyroid Carcinoma
NCT03647358
Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma
NCT03618550
Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients
NCT03587844
Talking to Employers and Medical Staff About Breast Cancer Treatment and Your Job
NCT03572374
Determining Whether Multiple Anesthesia Exposures Affect Cognitive Function for Retinoblastoma Patients
NCT03546387
New MRI Biomarkers in Head and Neck Cancers
NCT03483337
Assessment of Healing and Function After Reconstruction Surgery for Bone Sarcomas
NCT03442465
Responses to Genetic Risk Modifier Testing Among Women With BRCA1/2 Mutations
NCT03396341
Collecting Information About Treatment Results for Patients With Cushing's Syndrome
NCT03364803
Bupivacaine vs Placebo for Unilateral Mastectomy Surgical Site Post-operative Pain Control
NCT03351348
A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma
NCT03334708
Registry for Patients With Erdheim-Chester Disease and Other Histiocytoses
NCT03329274
A Study Comparing Quality of Life in Patients With Lymphedema Who Undergo Surgical Treatment Versus Non-Surgical Management
NCT03248310
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 461 |
| Phase 2 | 640 |
| Phase 3 | 67 |
| Phase 4 | 8 |
Therapeutic Areas
What is open in the Memorial Sloan Kettering Cancer Center pipeline
327 recruiting of 1,884 indexed (17% open); 1,104 completed (59%).
Phase mix: 75 late (III/IV) vs 1,101 early (I/II) (early-phase heavy).
Top condition: Breast Cancer (98 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.